CD24 and pancreatic adenocarcinoma: In their study, human Colo357 pancreatic adenocarcinoma cells were treated in vitro with anti-CD24 mABs, which resulted in the arrest of cell growth in a dose- and time-dependent manner, while the cells negative to CD24 expression were not similarly affected.